(5-Methylthiophen-2-yl)boronic acid → 7-(5-Methylthiophen-2-yl)pyrazolo[1,5-a]pyrimidin-5-amine
Reaktionsgleichung
Cl[C:2]1[N:7]2[N:8]=[CH:9][CH:10]=[C:6]2[N:5]=[C:4]([NH2:11])[CH:3]=1.[CH3:12][C:13]1[S:17][C:16](B(O)O)=[CH:15][CH:14]=1>>[CH3:12][C:13]1[S:17][C:16]([C:2]2[N:7]3[N:8]=[CH:9][CH:10]=[C:6]3[N:5]=[C:4]([NH2:11])[CH:3]=2)=[CH:15][CH:14]=1Komponenten
3
Versuchsvorschrift
The titled compound was prepared using a procedure analogous to that described in connection with Example 15 except that 7-chloropyrazolo[1,5-a]pyrimidin-5-amine (1E) and 5-methylthiophen-2-ylboronic acid were used as starting materials. 1H NMR (400 MHz, CHLOROFORM-d) δ 2.59 (s, 3H), 4.76 (s, 2H), 6.21 (d, J=1.8 Hz, 1H), 6.44 (s, 1H), 6.89 (d, J=3.5 Hz, 1H), 7.99-8.04 (m, 2H).
Quellen und Nachweise
- ORD-Eintrag
- ord-2d3c1731e6d14cf3b8110553b8a4f98d
- Quelldatensatz
- uspto-grants-2014_12
- Patentnummer
- US08921358B2
Notizen zur Reaktion
Wird geladen…